Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arnaud Valent

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
European Journal of Anaesthesiology|June 25, 2024
Neuromuscular blocking agent drug challenge: a literature review and protocol proposal with biological evaluationAurélie Gouel-Chéron, Catherine Neukirch, Sylvie Chollet-Martin, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 28, 2026
Imlifidase enables AAV gene therapy in a seropositive Crigler-Najjar patient: On the verge of a paradigm shiftJeremy Do Cao, Ji Gao-Desliens, Arnaud Valent, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 27, 2026
Death following high-dose AAV9 gene therapy in a patient with advanced SMA-PMEOdile Boespflug-Tanguy, Arnaud Valent, Jérôme Rambaud, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
European Journal of Anaesthesiology|June 25, 2024
Neuromuscular blocking agent drug challenge: a literature review and protocol proposal with biological evaluationAurélie Gouel-Chéron, Catherine Neukirch, Sylvie Chollet-Martin, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 28, 2026
Imlifidase enables AAV gene therapy in a seropositive Crigler-Najjar patient: On the verge of a paradigm shiftJeremy Do Cao, Ji Gao-Desliens, Arnaud Valent, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 27, 2026
Death following high-dose AAV9 gene therapy in a patient with advanced SMA-PMEOdile Boespflug-Tanguy, Arnaud Valent, Jérôme Rambaud, et al.
Pageof 2